Adicet Bio CEO Chen Schor's 2022 pay falls 59% to $4M

Adicet Bio reports 2022 executive compensation

By ExecPay News

Published: April 18, 2023

Adicet Bio reported fiscal year 2022 executive compensation information on April 18, 2023.
In 2022, three Adicet Bio executives received on average a compensation package of $2.8M, a 42% decrease compared to previous year.
Average pay of disclosed executives at Adicet Bio
Chen Schor, Chief Executive Officer, received $4M in total, which decreased by 59% compared to 2021. 77% of Schor's compensation, or $3.1M, was in option awards. Schor also received $310K in non-equity incentive plan, $562K in salary, as well as $28K in other compensation.
Blake Aftab, Chief Scientific Officer, received a compensation package of $2.5M. 73% of the compensation package, or $1.8M, was in option awards.
Francesco Galimi, Chief Medical Officer, earned $2M in 2022, a 15% decrease compared to previous year.

Related executives

Chen Schor

Adicet Bio

Chief Executive Officer

Blake Aftab

Adicet Bio

Chief Scientific Officer

Francesco Galimi

Adicet Bio

Chief Medical Officer

You may also like

Source: SEC filing on April 18, 2023.